The use of artificial intelligence (AI) in drug development has been hyped up for some time now – and the COVID-19 pandemic is finally a chance for these technologies to prove their worth.
Research into drugs that could treat or prevent COVID-19 continued full steam ahead this week as the industry puts all its resources into fighting the coronavirus pandemic.
So, what is this thing we call ‘empathetic technology’? While the two terms seem like antonyms, the intersection is proving to be a rich opportunity for innovation.